Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.25
+0.07 (0.63%)
Apr 30, 2026, 3:00 PM CST

SHA:603439 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
200.33389.42476.07571.37570.88544.22
Trading Asset Securities
175.9619.9322.9551.559.9198
Cash & Short-Term Investments
376.3409.34499.02622.87630.79642.22
Cash Growth
-10.24%-17.97%-19.89%-1.26%-1.78%10.72%
Accounts Receivable
878.55858.34932.12682.86432.82312.8
Other Receivables
2.543.022.533.322.1851.41
Receivables
881.08861.35934.65686.18435.01364.21
Inventory
207.19222.42320.72175.7298.0888.57
Other Current Assets
34.2336.4743.598.698.184.55
Total Current Assets
1,4991,5301,7981,4931,1721,100
Property, Plant & Equipment
543.04545.57585.15615.13237.4157.91
Long-Term Investments
89.3989.622.5510.08129.77119.13
Goodwill
432.63432.63554.61554.61161.66-
Other Intangible Assets
189.62194.28216.13235.23107.320.38
Long-Term Deferred Tax Assets
17.215.7915.1311.086.895.12
Long-Term Deferred Charges
0.570.660.560.861.542.9
Other Long-Term Assets
39.4739.81----
Total Assets
2,8112,8483,1922,9201,8171,405
Accounts Payable
111.64112.29342.73247.98165.2698.84
Accrued Expenses
12.5534.0167.3339.4831.3316.59
Short-Term Debt
498.32548.67351.52255.32205200
Current Portion of Long-Term Debt
60.0259.9145.1545.22--
Current Portion of Leases
--0.50.150.5-
Current Income Taxes Payable
40.4555.313.8412.7710.919.4
Current Unearned Revenue
4.175.477.798.1778.965.83
Other Current Liabilities
226.75221.53405.59229.9256.7229.76
Total Current Liabilities
953.891,0371,234839.01548.68360.42
Long-Term Debt
149.5149.72209.3254.15--
Long-Term Leases
-0.030.210.170.17-
Long-Term Unearned Revenue
38.1739.1942.9735.9712.512.5
Long-Term Deferred Tax Liabilities
21.1421.9925.528.886.94-
Other Long-Term Liabilities
87.3587.5985.0452.9210.1-
Total Liabilities
1,2501,3361,5971,211578.4372.93
Common Stock
408.93408.93409.8409.86410.86410.86
Additional Paid-In Capital
156.47153.26149.04225.12229.69223.39
Retained Earnings
1,022977.751,069876.75625.04423.75
Treasury Stock
-94.35-94.35-100.64-41.43-26.55-26.55
Total Common Equity
1,4931,4461,5271,4701,2391,031
Minority Interest
67.4666.6367.29239.04-0.820.61
Shareholders' Equity
1,5611,5121,5951,7091,2381,032
Total Liabilities & Equity
2,8112,8483,1922,9201,8171,405
Total Debt
707.84758.32606.68555.02205.67200
Net Cash (Debt)
-331.54-348.98-107.6767.86425.12442.22
Net Cash Growth
----84.04%-3.87%16.36%
Net Cash Per Share
-0.80-0.83-0.260.161.031.07
Filing Date Shares Outstanding
403.74470.17405.61408.25410.86410.86
Total Common Shares Outstanding
403.74470.17405.61408.25410.86410.86
Working Capital
544.91492.42563.53654.46623.38739.12
Book Value Per Share
3.703.073.773.603.022.51
Tangible Book Value
870.96818.69756.61680.48970.091,011
Tangible Book Value Per Share
2.161.741.871.672.362.46
Buildings
--543.28549.09181.14152.85
Machinery
--351.45344.91103.2758.44
Construction In Progress
---0.0448.594.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.